QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: mol.108.052381v1 75/2/324    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Larson, C. A. Articles by Howell, S. B. Search for Related Content PubMed PubMed Citation Articles by Larson, C. A. Articles by Howell, S. B.

The Role of the Mammalian Copper Transporter 1 in the Cellular Accumulation of Platinum-Based Drugs

Moores Cancer Center and Department of Medicine, University of California, San Diego, La Jolla, California

The mammalian copper transporter 1 (CTR1) is responsible for the uptake of copper from the extracellular space. In this study, we used an isogenic pair of CTR1(+/+) and CTR1(-/-) mouse embryo fibroblasts to examine the contribution of CTR1 to the influx of cisplatin (DDP), carboplatin (CBDCA), oxaliplatin (L-OHP), and transplatin. Exposure to DDP triggered the rapid degradation of CTR1, suggesting that its contribution to influx was likely to be on the initial phase of drug entry. Loss of CTR1 decreased the initial binding of DDP to cells and reduced influx measured over the first 5 min of drug exposure by 81%. Loss of CTR1 almost completely eliminated the initial influx of CBDCA and reduced the initial uptake of L-OHP by 68% but had no effect on the influx of transplatin. Loss of CTR1 rendered cells resistant to even high concentrations of DDP when measured in vitro, and re-expression of CTR1 in the CTR1(-/-) cells restored both DDP uptake and cytotoxicity. The growth of CTR1(-/-) tumor xenografts in which CTR1 levels were restored by infection with a lentivirus expressing wild-type CTR1 was reduced by a single maximum tolerated dose of DDP in vivo, whereas the CTR1(-/-) xenografts failed to respond at all. We conclude that CTR1 mediates the initial influx of DDP, CBDCA, and L-OHP and is a major determinant of responsiveness to DDP both in vitro and in vivo.

Received for publication October 1, 2008.

Accepted for publication November 7, 2008.

Address correspondence to: Dr. Stephen B. Howell, Moores UCSD Cancer Center, 3855 Health Sciences Drive, #0819, La Jolla, CA 92093. E-mail: showell{at}ucsd.edu

This article has been cited by other articles:

				B. G. Blair, C. A. Larson, R. Safaei, and S. B. Howell Copper Transporter 2 Regulates the Cellular Accumulation and Cytotoxicity of Cisplatin and Carboplatin Clin. Cancer Res., July 1, 2009; 15(13): 4312 - 4321. [Abstract] [Full Text] [PDF]